LEADER 05486nam 22009735 450 001 9910380742003321 005 20230822223102.0 010 $a3-030-35918-2 024 7 $a10.1007/978-3-030-35918-8 035 $a(CKB)4100000010480423 035 $a(DE-He213)978-3-030-35918-8 035 $a(MiAaPQ)EBC6122108 035 $a(Au-PeEL)EBL6122108 035 $a(OCoLC)1143625864 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/31058 035 $a(PPN)24298164X 035 $a(EXLCZ)994100000010480423 100 $a20200219d2020 u| 0 101 0 $aeng 135 $aurnn#008mamaa 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aAdvances in Pharma Business Management and Research$b[electronic resource] $eVolume 1 /$fedited by Lars Schweizer, Theodor Dingermann, Otto Quintus Russe, Christian Jansen 205 $a1st ed. 2020. 210 $cSpringer Nature$d2020 210 1$aCham :$cSpringer International Publishing :$cImprint: Springer,$d2020. 215 $a1 online resource (X, 85 p. 11 illus.) 311 $a3-030-35917-4 327 $aChapter 1. Introduction: Trends and developments in the pharmaceutical and life sciences industry -- Chapter 2. Relevance of instruments for measurements of Quality of Life in the AMNOG Context -- Chapter 3. The quality management system for R&D project and portfolio management in a pharmaceutical company -- Chapter 4. Brexit and Its Impact on Pharmaceutical Law - Implications for global pharma companies -- Chapter 5. Implementation of Measurable and Sustainable Actions to Improve Employee?s Engagement and Business Performance - Global Medical Clinical & Regulatory Affairs (GMCRA) ? A Role Model at Fresenius Kabi -- Chapter 6. Leadership Models and Work Behavior: An Empirical Analysis of Consequences of Authentic and Transformational Leadership -- Chapter 7. Alliance Management at Merck - Establishing an operational 100-day plan for alliance launches and management. 330 $aThis open access book presents a unique collection of practical examples from the field of pharma business management and research. It covers a wide range of topics such as: 'Brexit and its Impact on pharmaceutical Law - Implications for Global Pharma Companies', 'Implementation of Measures and Sustainable Actions to Improve Employee's Engagement', 'Global Medical Clinical and Regulatory Affairs (GMCRA)', and 'A Quality Management System for R&D Project and Portfolio Management in a Pharmaceutical Company'. The chapters are summaries of master?s theses by "high potential" Pharma MBA students from the Goethe Business School, Frankfurt/Main, Germany, with 8-10 years of work experience and are based on scientific know-how and real-world experience. The authors applied their interdisciplinary knowledge gained in 22 months of studies in the MBA program to selected practical themes drawn from their daily business. 606 $aPharmaceutical technology 606 $aHealth care management 606 $aHealth services administration 606 $aMedical laws and legislation 606 $aPharmacy 606 $aPharmacy management 606 $aPharmaceutical Sciences/Technology$3https://scigraph.springernature.com/ontologies/product-market-codes/B21010 606 $aHealth Care Management$3https://scigraph.springernature.com/ontologies/product-market-codes/527030 606 $aMedical Law$3https://scigraph.springernature.com/ontologies/product-market-codes/R16005 606 $aPharmacy$3https://scigraph.springernature.com/ontologies/product-market-codes/F00008 606 $aPharmacoeconomics and Health Outcomes$3https://scigraph.springernature.com/ontologies/product-market-codes/H69020 610 $aPharmaceutical Sciences/Technology 610 $aHealth Care Management 610 $aMedical Law 610 $aPharmacy 610 $aPharmacoeconomics and Health Outcomes 610 $aPharmaceutics 610 $aHealth Care 610 $aPharmacology 610 $aPharma Management 610 $aMarket Access 610 $aRegulatory Affairs 610 $aResearch & Development 610 $aQuality Control 610 $aOpen Access 610 $aIndustrial chemistry & chemical engineering 610 $aHealth economics 610 $aMedical & healthcare law 610 $aPharmacy / dispensing 615 0$aPharmaceutical technology. 615 0$aHealth care management. 615 0$aHealth services administration. 615 0$aMedical laws and legislation. 615 0$aPharmacy. 615 0$aPharmacy management. 615 14$aPharmaceutical Sciences/Technology. 615 24$aHealth Care Management. 615 24$aMedical Law. 615 24$aPharmacy. 615 24$aPharmacoeconomics and Health Outcomes. 676 $a615.19 700 $aSchweizer$b Lars$4edt$01356483 702 $aSchweizer$b Lars$4edt$4http://id.loc.gov/vocabulary/relators/edt 702 $aDingermann$b Theodor$4edt$4http://id.loc.gov/vocabulary/relators/edt 702 $aRusse$b Otto Quintus$4edt$4http://id.loc.gov/vocabulary/relators/edt 702 $aJansen$b Christian$4edt$4http://id.loc.gov/vocabulary/relators/edt 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910380742003321 996 $aAdvances in Pharma Business Management and Research$93361062 997 $aUNINA